Some pharmaceutical companies developing Covid-19 vaccine candidates have pledged to not take a profit. But neither the companies nor the U.S. government bankrolling the vaccine research has defined what forgoing a profit means or how long that will last
Some of the pharmaceutical companies developing Covid-19 vaccine candidates have pledged to not take a profit.
Lawmakers say they don’t know how the coronavirus vaccines will be priced, or how much money governments, in the U.S. and abroad, may have to spend to purchase millions, if not billions, of doses to halt the pandemic, on top of the spending on research and production. “How has that cost been determined? For how long will it be available? Is this just a clever marketing strategy?” added Doggett, who complained it’s hard to get information on coronavirus drugs and vaccines because the “Trump administration that’s dominated by former pharmaceutical executives, won’t tell.”
“I’m not saying [vaccine developers] don’t have any interest in protecting public health, but their business is about maximizing their returns for investors,” Sen. Tina Smith said in a phone interview. Any profit should be “reasonable” — and government should be able to verify that, she added.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Gabriela Hearst and Net-a-Porter Launch Bags of Purpose to Help Fight COVID-19Twenty percent of profits will go to Save the Children’s global Coronavirus Response Fund.
Read more »
'No one is safe until everyone is safe': Vaccine nationalism threatens global coronavirus effortRather than widespread collaboration, coordination and sharing, 'me first' vaccine nationalism pits nation against nation to get and keep enough doses for their citizens.
Read more »
Thailand plans November human testing for potential coronavirus vaccineThai researchers plan to begin human trials of a potential vaccine for the new coronavirus in November and are preparing 10,000 doses, a senior official said on Sunday, aiming for a vaccine that could be ready for use by late next year.
Read more »
Covid-19 Vaccine Trials Now Open To Volunteers In U.S.The National Institute of Allergy and Infectious Diseases launched the website Covid-19 Prevention Network on Wednesday, merging four existing clinical trial networks and setting up an operation across over 100 different sites in the United States and internationally.
Read more »
Pfizer, BioNTech's coronavirus vaccine candidates get FDA's 'fast track' statusTwo experimental coronavirus vaccines jointly developed by German biotech firm BioNTech and U.S. pharmaceutical giant Pfizer have received 'fast track' designation from the U.S. drug regulator, the companies said on Monday.
Read more »
Stock market live updates: Dow futures jump 200 points, vaccine hopes, Big Tech higherThis is CNBC's live blog covering the latest market-moving news. Here's what's happening.
Read more »